{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:49:01Z","timestamp":1794851341273,"version":"4.9.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.vaccine.2009.01.131","type":"journal-article","created":{"date-parts":[[2009,2,7]],"date-time":"2009-02-07T05:52:28Z","timestamp":1233985948000},"page":"2042-2047","source":"Crossref","is-referenced-by-count":13,"title":["Surveillance of Vaccine Safety: Comparison of parental reports with routine surveillance and a clinical trial"],"prefix":"10.1016","volume":"27","author":[{"given":"Eva","family":"Netterlid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Edwinson","family":"M\u00e5nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"H\u00e5kansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.01.131_bib1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S1473-3099(06)70605-3","article-title":"Adverse events following immunisation: desperately seeking surveillance","volume":"6","author":"Buttery","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2009.01.131_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/eurpub\/cki194","article-title":"Understanding variation in measles-mumps-rubella immunization coverage\u2014a population-based study","volume":"16","author":"Wright","year":"2006","journal-title":"Eur J Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2009.01.131_bib3","first-page":"178","article-title":"Monitoring signals for vaccine safety: the assessment of individual adverse event reports by an expert advisory committee","volume":"78","author":"Collet","year":"2000","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1016\/j.vaccine.2009.01.131_bib4","first-page":"153","article-title":"Immunization safety: a global priority","volume":"78","author":"Scholtz","year":"2000","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1016\/j.vaccine.2009.01.131_bib5","first-page":"170","article-title":"Developing a national system for dealing with adverse events following immunization","volume":"78","author":"Metha","year":"2000","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1016\/j.vaccine.2009.01.131_bib6","first-page":"205","article-title":"Vaccine adverse events in the new millennium: is there reason for concern?","volume":"78","author":"Ward","year":"2000","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2009.01.131_bib7","unstructured":"L\u00e4kemedelsverket [Medical Products Agency]. [Monitoring adverse drug reactions] [Internet]. Uppsala (Sweden). [updated 2007 May 16; cited 2007 July 12]. Available from: http:\/\/www.lakemedelsverket.se\/Tpl\/NormalPage_127.aspx. Swedish."},{"issue":"11","key":"10.1016\/j.vaccine.2009.01.131_bib8","first-page":"828","article-title":"Vaccinovigilance in Europe\u2014need for timeliness, standardization and resources","volume":"82","author":"Lankinen","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"6","key":"10.1016\/j.vaccine.2009.01.131_bib9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0264-410X(94)90315-8","article-title":"The Vaccine Adverse Event Reporting System (VAERS)","volume":"12","author":"Chen","year":"1994","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.01.131_bib10","first-page":"1","article-title":"Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)\u2014United States, 1991\u20132001","volume":"52","author":"Zhou","year":"2003","journal-title":"MMWR"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.01.131_bib11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1542\/peds.99.6.765","article-title":"Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team","volume":"99","author":"Chen","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2009.01.131_bib12","unstructured":"Medicines and Healthcare Products Regulatory Agency (MHRA) Reporting suspected adverse drug reactions and suspected defects in medicinal products. http:\/\/www.mhra.gov.uk\/Safetyinformation\/Reportingsafetyproblems\/Medicines\/index.htm. Accessed 2009 January 20."},{"key":"10.1016\/j.vaccine.2009.01.131_bib13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.vaccine.2003.09.005","article-title":"Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation","volume":"22","author":"Rothstein","year":"2004","journal-title":"Vaccine"},{"issue":"August (31)","key":"10.1016\/j.vaccine.2009.01.131_bib14","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1016\/j.vaccine.2007.04.056","article-title":"Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data","volume":"25","author":"Kohl","year":"2007","journal-title":"Vaccine"},{"issue":"December (52)","key":"10.1016\/j.vaccine.2009.01.131_bib15","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1016\/j.vaccine.2008.10.006","article-title":"A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data","volume":"26","author":"Gidudu","year":"2008","journal-title":"Vaccine"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.01.131_bib16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00006454-200004000-00003","article-title":"Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults","volume":"19","author":"Halperin","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.01.131_bib17","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1542\/peds.105.1.e12","article-title":"Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines","volume":"105","author":"Rennels","year":"2000","journal-title":"Pediatrics"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.01.131_bib18","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1542\/peds.105.1.e11","article-title":"Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children","volume":"105","author":"Pichichero","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2009.01.131_bib19","doi-asserted-by":"crossref","unstructured":"Olin P, Rasmusson F, Hallander HO, Heijbel H, for the Ad Hoc Group for the Study of Pertussis Vaccines: Randomised controlled trial of two-component, three-component, and five-component acellular vaccines compared with whole-cell pertussis vaccine. Lancet 1997;350November (9091):1569\u201377.","DOI":"10.1016\/S0140-6736(97)06508-2"},{"key":"10.1016\/j.vaccine.2009.01.131_bib20","unstructured":"Olin P, Carlsson RM, Johansen K, Hallander H, Ljungman M, Svensson \u00c5, et al. Vaccinationsuppf\u00f6ljning Seroepidemiologisk tv\u00e4rsnittsstudie. Final report. 1997. Stockholm (Sweden). Smittskyddinstitutets rapportserie 3:2004. Swedish."},{"key":"10.1016\/j.vaccine.2009.01.131_bib21","unstructured":"Gustafsson L, Hallander HO, Netterlid E, Reizenstein E, Olin P. Antibody responses and clinical reactions to booster doses of TdcP+IPV, TdcP-IPV or DT+IPV at 5\u00bd years of age after primary immunisation with DTcP (DTPa5) at 3, 5 and 12 months of age in Pertussis Vaccine Trial II. Technical Report. 2000 Sept 9. Available from the Swedish Institute for Infectious Disease Control official register."},{"key":"10.1016\/j.vaccine.2009.01.131_bib22","unstructured":"Communicable Diseases in Sweden 2001: The annual report of the Department of Epidemiology [PDF]. Stockholm: Smittskyddsinsitutet. Available from: http:\/\/www.smittskyddsinstitutet.se\/upload\/Publikationer\/Report2001.pdf."},{"issue":"12","key":"10.1016\/j.vaccine.2009.01.131_bib23","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2105\/AJPH.85.12.1706","article-title":"The reporting sensitivities of two passive surveillance system for vaccine adverse events","volume":"85","author":"Rosenthal","year":"1995","journal-title":"Am J Public Health"},{"issue":"September (13)","key":"10.1016\/j.vaccine.2009.01.131_bib24","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0264-410X(96)00092-8","article-title":"Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III","volume":"14","author":"Aggerbeck","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.131_bib25","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0264-410X(98)00410-1","article-title":"Subcutaneus versus intramuscular injection for booster DT vaccination of adolescents","volume":"17","author":"Mark","year":"1999","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.01.131_bib26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1651-2227.1994.tb13042.x","article-title":"The role of aluminium for adverse reactions and immunogenicity of diphtheria-tetanus booster vaccine","volume":"83","author":"Mark","year":"1994","journal-title":"Acta P\u00e6diatr"},{"issue":"5","key":"10.1016\/j.vaccine.2009.01.131_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0264-410X(94)90119-8","article-title":"Adverse reaction after diphtheria-tetanus booster in 10-year-old schoolchildren in relation to the type of vaccine given for the primary vaccination","volume":"12","author":"Blennow","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.131_bib28","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.puhe.2006.03.011","article-title":"Is the cultural context of MMR rejection a key to an effective health discourse?","volume":"120","author":"Cassell","year":"2006","journal-title":"Public Health"},{"key":"10.1016\/j.vaccine.2009.01.131_bib29","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1016\/j.vaccine.2006.05.029","article-title":"An internet-based survey on parental attitudes towards immunization","volume":"24","author":"Heininger","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.131_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/02813430510031306","article-title":"Parents\u2019 reported reasons for avoiding MMR vaccination","volume":"23","author":"Dannetun","year":"2005","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.vaccine.2009.01.131_bib31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0025-6196(11)64183-9","article-title":"Vaccine safety: injecting a dose of common sense","volume":"75","author":"Poland","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.vaccine.2009.01.131_bib32","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0277-9536(99)00239-7","article-title":"Patterns of vaccine acceptance","volume":"49","author":"Streefland","year":"1999","journal-title":"Soc Sci Med"},{"issue":"April (0)","key":"10.1016\/j.vaccine.2009.01.131_bib33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S1473-3099(09)70290-7","article-title":"Risky business of vaccine safety","volume":"1","author":"Balinska","year":"2001","journal-title":"Lancet (Infect Dis Suppl)"},{"issue":"October (7266)","key":"10.1016\/j.vaccine.2009.01.131_bib34","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/bmj.321.7266.931","article-title":"Effect on needle length on incidence of local reactions to routine immunisation in infants aged 4 months: randomised controlled trial","volume":"321","author":"Diggle","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2009.01.131_bib35","unstructured":"EUSAFEVAC. Final Report 2004-03-01, Available at http:\/\/www.smittskyddsinstitutet.se\/amnesomraden\/vaccinationer\/eusafevac\/eusafevac-documents\/ Accessed 2009 January 20."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09001972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09001972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T17:53:50Z","timestamp":1558115630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09001972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":35,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0264410X09001972"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.01.131","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}